Login

Viorel Panait de la Comvex: Spotlight at Financial Intelligence's 2023 Capital Market Forum | Panait Viorel - CEO of Comvex 00:10:00

Share On Facebook Share On Twitter

Panait Viorel is the CEO of Comvex Constanta.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Invests in healthcare and technology in the US and Europe|David Jegen,Managing Partner,F Prime Capital fka Fidelity Biosciences
00:10:00
Driving Clean Energy Transition: A Discussion on Renewable Energy Expansion| Eric Francia, CEO, Acen Corp.
00:10:00
NuScale Power Secures $40 Million Investment from JGC Holdings for SMR Deployment | Masayuki Sato - Representative Director, Chairman and CEO of JGC Holdings Corporation
00:10:00
Édouard Guinotte, CEO of Vallourec: Breaking Gender Bias and Empowering Women | Édouard Guinotte, CEO, Vallourec SA.
00:10:00
Staying True: The Journey of a Quant Investor | Cliff Asness, Chief Investment Officer , AQR Capital.
00:10:00
Investing for retirement made easier | Ron Peyton,CEO and executive chairman, CIT Callan International Equity Fund
00:10:00
Vantage Towers' M&A Ambitions: CFO Thomas Reisten on Industry Growth and Expansion | Thomas Reisten, CFO , Vantage Towers AG.
00:10:00
Aiforia: Taustalla tapahtuu | Jukka Tapaninen, CEO, Aiforia Technologies OyjAIFORIA:HEX
00:10:00
Aston Bay's Storm Project Update with CEO Tom M: May 2024 Metal Investors Forum
00:00:00
Eric Poma, CEO of Molecular Templates
00:10:00
The impact of Covid-related travel disruptions, and Darrin’s views on the best and worst aspects of being a listed company|Darrin Grafton,CEO, Serko
00:10:00
Spotting Talent Before It Shines: How This VC Bets on Untapped Potential|Alana Goyal,Founder and Managing Partner,base case capital

© 2017 - Neuhu+